Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis

Chuang, Min-HsiangMin-HsiangChuangTang, Yu-ShuoYu-ShuoTangChen, Jui-YiJui-YiChenPan, Heng-ChihHeng-ChihPanLiao, Hung-WeiHung-WeiLiaoChu, Wen-KaiWen-KaiChuCheng, Chung-YiChung-YiChengVIN-CENT WUHeung, MichaelMichaelHeung2024-04-292024-04-292024-032233-60792233-6087https://scholars.lib.ntu.edu.tw/handle/123456789/642123The initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2i) typically leads to a reversible initial dip in estimated glomerular filtration rate (eGFR). The implications of this phenomenon on clinical outcomes are not well-defined.enDiabetes mellitus, type 2; Glomerular filtration rate; Kidney; Sodium-glucose transporter 2 inhibitors[SDGs]SDG3Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysisjournal article10.4093/dmj.2023.0201382737902-s2.0-85189720023https://api.elsevier.com/content/abstract/scopus_id/85189720023